From the helm: Saluda Medical (ASX:SLD), President & CEO, Barry Regan

Bell Direct
March 20, 2026

In this episode of From the Helm, Grady chats with Saluda Medical (ASX:SM1) President and CEO Barry Regan to discuss their recent developments since their IPO in November, their developmental drug for the treatment of chronic pain, and what is on the horizon looking ahead.

Market Update

Julia Lee
April 24, 2017

Market Update

Bell Direct
April 21, 2017

Market Update

Bell Direct
April 20, 2017

Market Update

Bell Direct
April 19, 2017

Market Update

Bell Direct
April 18, 2017

Market Update

Bell Direct
April 13, 2017

Market Update

Bell Direct
April 12, 2017

Market Update

Bell Direct
April 11, 2017

Market Update

Bell Direct
April 10, 2017

Market Update

Julia Lee
April 7, 2017

Market Update

Julia Lee
April 6, 2017

Market Update

Julia Lee
April 5, 2017